-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on ArcBest, Lowers Price Target to $146

Benzinga·11/06/2026 01:06:00
Listen to the news
UBS analyst Thomas Wadewitz maintains ArcBest (NASDAQ:ARCB) with a Neutral and lowers the price target from $154 to $146.